Prescription Drug MonitoringProgram leads to reduced opioids prescription, in-patient stays and ED
Prescription Drug Monitoring Program leads to reduced opioids prescription, in-patient stays and ED visits
Heather Landi, September 4, 2019. Fierce Healthcare
Summarized by: Sara Supriyatno
According to a study published in Health Affairs, the use of prescription drug monitoring programs (PDMPs) have been successful in lowering the rates of opioid prescription and significantly reducing the opioid-related emergency department (ED) visit rate. Forty-nine states that mandate PDMPs require prescriber and dispenser to register controlled substances. According to the study performed in the Medicaid population, the use of the program was associated with nearly 9% lower opioids prescription rate, 4.27% decrease in opioid related in-patient stays and 17.75% in Emergency Department visits. There had been concerns expressing that the restricted access to opioids prescription may result in drug-dependent individuals to seek more harmful alternatives, such as heroin and fentanyl. However, the study investigators state that “increases [in illegal alternatives], if any, were offset by the reduction in prescription opioid-related events." Overall, the program is effective in helping providers in identifying high-risk patients and refer them to opioid-used disorder treatments and interventions.
Photo Credit: https://www.fiercehealthcare.com/tech/use-prescription-drug-databases-leads-to-lower-rates-opioid-related-inpatient-stays-and-ed